Updated Results from Phase I Study of CB-839 in Combination with Paclitaxel in Patients with Triple Negative Breast Cancer to be Presented at the 2017 San Antonio Breast Cancer Symposium
December 05, 2017 08:00 ET
|
Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on discovering and developing novel small...
![livingbeyondbreastcancer](/news-release/logo/329934/0/329934.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A12&size=2)
Living Beyond Breast Cancer to Host
July 08, 2015 09:07 ET
|
Living Beyond Breast Cancer
PHILADELPHIA, PA., July 8, 2015 (GLOBE NEWSWIRE) -- In a brand new format to provide both information and support, Living Beyond Breast Cancer (LBBC) has announced that registration is now open for...
![livingbeyondbreastcancer](/news-release/logo/329934/0/329934.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A12&size=2)
Hot topics in breast cancer this Spring from LBBC
February 26, 2015 11:26 ET
|
Living Beyond Breast Cancer
HAVERFORD, PA., Feb. 26, 2015 (GLOBE NEWSWIRE) -- This spring, Living Beyond Breast Cancer (LBBC) releases research, hosts events, and publishes guides that help inform and support individuals who may...